Navigation Links
Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop
Date:5/26/2009

BUDAPEST, Hungary and EXTON, Pa., May 26 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced the presentation of five abstracts relating to Cinryze(TM) (C1 esterase inhibitor [human]) therapy at the 6th Annual C1 Inhibitor Deficiency Workshop.

Cinryze was approved by the U.S. Food and Drug Administration in October 2008 for routine prophylaxis against hereditary angioedema (HAE) attacks in adults and adolescents. In February 2009, ViroPharma was granted priority review of a supplemental Biologics License Application for Cinryze for the treatment of acute attacks of HAE. If approved, Cinryze would be the first C1 esterase inhibitor available for the acute treatment for this condition. ViroPharma's PDUFA date for Cinryze in the acute setting is June 3, 2009.

"With the C1 Inhibitor Deficiency Workshop presentations focusing on items including HAE treatment considerations and the potential for subcutaneous infusion, among others, ViroPharma is demonstrating our commitment to meeting the needs of patients with C1 deficiency diseases today, and tomorrow," commented Glenn Tillotson, ViroPharma's senior director and head of Medical Affairs.

The following abstracts from studies supported by Lev Pharmaceuticals, a company acquired by ViroPharma Incorporated in October 2008, were presented:

Abstract book page 27: Prophylactic Therapy Considerations in Hereditary Angioedema

  • In an abstract entitled, 'When Should Prophylactic Therapy be Considered for Hereditary Angioedema?', Dr. Tim Craig, et al. described how a literature review, guideline analysis from other countries, expert panel meeting, and consensus development were conducted in order to develop therapy considerations for prophylaxis of HAE in the U.S.;
  • The
    '/>"/>

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial
2. Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
3. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
4. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
5. Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientifics TAXUS(R) Liberte(R) Stent
6. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
7. Clinical Data Reinforce Safety and Efficacy of Boston Scientifics Two Drug- Eluting Stent Platforms
8. Results From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session
9. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
10. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
11. Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... DIEGO , July 11, 2014 Neurelis, ... Corp. ("Biotie") to end the option held by Biotie ... commence further development of NRL-1 (intranasal diazepam) for pediatric ... Over the past year, Biotie has advanced ... in preparation for the pivotal clinical work required for ...
(Date:7/10/2014)...  The U.S. Department of Health and Human Services ... (UH) Case Medical Center Seidman Cancer Center totaling $4.7 ... improving care for patients with complex cancer. ... a unique model developed at UH to enhance care ... or demonstrated need for high health care utilization.  ...
(Date:7/10/2014)... 10, 2014  RESMED INC. (NYSE: RMD ) ... fiscal year ended June 30, 2014 results on Thursday, July ... A press release with ResMed,s results will be issued after ... a webcast to discuss operating results and future outlook. ... p.m. US Pacific Time and the live webcast of the ...
Breaking Medicine Technology:Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
... ChromaDex® Corp. (OTCBB: CDXC) today announced that the ... exclusive rights to a joint patent application filed ... of inducing UDP-glucuronosyltransferase (UGT) activity using pTeroPure®, ChromaDex®,s ... blueberries and demonstrated to have multiple health benefits. ...
... Abaxis, Inc. (NasdaqGS: ABAX), a medical products company ... Serverson, chief executive officer,  will present at 2011 Morgan ... 2011 at 10:20 a.m. ET at the Grand Hyatt ... markets and sells portable blood analysis systems for use ...
Cached Medicine Technology:ChromaDex®'s Novel Ingredient pTeroPure® to be Studied as Potential Treatment for Fighting Skin Cancers 2ChromaDex®'s Novel Ingredient pTeroPure® to be Studied as Potential Treatment for Fighting Skin Cancers 3Abaxis to Present at 2011 Morgan Stanley Global Healthcare Unplugged Conference 2
(Date:7/14/2014)... Love Digits LLC has successfully launched its ... App brings ancient astrology to the modern dating scene, ... using a five-star rating system. By entering their birth ... their compatibility for love and marriage across seven different ... rating system generates a weighted average of the seven ...
(Date:7/14/2014)... WA (PRWEB) July 14, 2014 ... solutions, today announced its new IBM i (AS/400, ... Software Vendors (ISVs). As security threats evolve and ... software providers struggle to modernize their applications and ... program now makes it easy for ISVs on ...
(Date:7/13/2014)... Florida (PRWEB) July 14, 2014 Save the ... Wolfson Children’s Hospital in Jacksonville, FL , BOXWOODS & BowTies ... 5-7, 2014 , Who: The Women’s Board of Wolfson ... & Antiques Show to continue their ongoing commitment to ... the region’s children. , What: The 2014 Art & ...
(Date:7/13/2014)... TopDresses100.com, a popular dress company in the global market, ... dresses to its product line. According to the ... guaranteed to be quality made. Now, they are offered ... has a wide variety of elegant dresses for customers ... stock and ready to ship. As an innovation-based supplier, ...
(Date:7/13/2014)... July 14, 2014 Recently, iFitDress.com, one ... has released its beautiful collection of brown evening ... outfits are now available at discounted prices, up to ... are of high quality; they are carefully made according ... special occasion gowns, iFitDress.com also offers pretty accessories: wedding ...
Breaking Medicine News(10 mins):Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 2Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 3Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 2Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 3Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 2Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 3Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 4Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 5Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 6Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 7Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 8Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 9Health News:Cheap Multi-colored Quinceanera Dresses From TopDresses100.com 2Health News:2014 Brown Evening Dresses Added To iFitDress.com 2
... Latex Ltd., will be launched next week commercially in select ... 30,000 pieces of female condoms across the country and from ... decided it is time to enter the market. This would ... country,' M. Ayyappan, chairman and managing director of the company, ...
... cancer researchers from all over the world are going to ... what exactly their risk of developing a melanoma is. // ... Leeds, England has been awarded a fund of ?7 million. ... the world. All these teams are working on the genetics ...
... identified by the Oregon National Primate Research Center at ... to control stem cells becoming other brain cells.// New ... and brain injury as a result of continued research. ... early stages before birth, which become glial cells in ...
... C.difficile’s genetic code is reported to have been cracked ... enable faster diagnosis and treatment of the ailment which ... the Jewish General Hospital’s Dasval. The strain has caused ... Quebec. The search can now commence for the other ...
... in his new book 'The Failure of Democratic Nation Building: ... says that Democracy should not or cannot be forcibly thrusted ... with an intrinsic need for hierarchical and authoritarian social and ... other hand requires unique conditions before it is accepted by ...
... team from Universite de Montreal have found that ... endocannabinoids by blocking the degradation in the brain ... brain which is responsible for relaxing brain, endocannabinoids ... during exercises and other well-being activities. The level ...
Cached Medicine News:
The Nevyas Drape Support is the simple and inexpensive way to establish a zone of comfort for your patients during ophthalmic surgery which requires draping over the nose and mouth. Packaged in sets ...
... important standard in busy operating rooms. The unique ... and supports arms and wrists during ophthalmic surgery. ... fluids are collected. The bar also flips up ... transfer on and off the table. The metal ...
... system provides patients with the ability ... to reading. The telescope has ... viewing. The double lens caps ... 4x magnifications. Each flip-up reading ...
The TV-Mag is a 1.9x focusing telescope, used mainly for watching television. It has a large objective lens giving excellent light transmission and a wide field of view....
Medicine Products: